Indication
Reflux esophagitis
Reflux esophagitis is an inflammatory disorder of the gastrointestinal system characterized by mucosal injury and inflammation of the distal esophagus. Read more about Reflux esophagitis
132 drugs 108 manufacturers
Drugs that treat it
Common Reflux esophagitis therapies.
FAMOTIDINE-0.9% NACL (famotidine in 0.9 % sodium chloride)
ACID CONTROLLER (famotidine)
PEPCID (famotidine)
FAMOTIDINE
ESOMEPRAZOLE SODIUM
ACID CONTROLLER (famotidine)
FAMOTIDINE (famotidine/PF)
FAMOTIDINE IN 0.9 % NACL (famotidine in 0.9 % sodium chloride)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonReflux esophagitis is an inflammatory disorder of the gastrointestinal system characterized by mucosal injury and inflammation of the distal esophagus.
It represents an objective, erosive manifestation of gastroesophageal reflux disease, primarily occurring in adults when gastric acid, pepsin, and bile persistently backflow past an incompetent lower esophageal sphincter.
Pathophysiologically, this chemical exposure disrupts the epithelial barrier, triggering a cytokine-mediated inflammatory response that leads to visible mucosal breaks, erosions, or ulcerations.
Clinically, affected patients commonly present with persistent heartburn, acid regurgitation, chest pain, and dysphagia, and prolonged inflammation may progress to complications such as peptic strictures or Barrett's esophagus.
- nih.gov
Reflux esophagitis is an inflammatory disorder of the gastrointestinal system characterized by mucosal injury and inflammation of the distal esophagus Clinically, affected patients commonly present with persistent heartburn, acid regurgitation, chest pain, and dysphagia, and prolonged inflammation may progress to complications such as peptic strictures or Barrett's esophagus
- endoscopy-campus.com
Reflux esophagitis is an inflammatory disorder of the gastrointestinal system characterized by mucosal injury and inflammation of the distal esophagus Pathophysiologically, this chemical exposure disrupts the epithelial barrier, triggering a cytokine-mediated inflammatory response that leads to visible mucosal breaks, erosions, or ulcerations Clinically, affected patients commonly present with persistent heartburn, acid regurgitation, chest pain, and dysphagia, and prolonged inflammation may pro...
- medlineplus.gov
It represents an objective, erosive manifestation of gastroesophageal reflux disease, primarily occurring in adults when gastric acid, pepsin, and bile persistently backflow past an incompetent lower esophageal sphincter
- nih.gov
It represents an objective, erosive manifestation of gastroesophageal reflux disease, primarily occurring in adults when gastric acid, pepsin, and bile persistently backflow past an incompetent lower esophageal sphincter
- clinicasgastroenterologiademexico.com
It represents an objective, erosive manifestation of gastroesophageal reflux disease, primarily occurring in adults when gastric acid, pepsin, and bile persistently backflow past an incompetent lower esophageal sphincter Pathophysiologically, this chemical exposure disrupts the epithelial barrier, triggering a cytokine-mediated inflammatory response that leads to visible mucosal breaks, erosions, or ulcerations Clinically, affected patients commonly present with persistent heartburn, acid regurg...
- bariatrictimes.com
Pathophysiologically, this chemical exposure disrupts the epithelial barrier, triggering a cytokine-mediated inflammatory response that leads to visible mucosal breaks, erosions, or ulcerations
- medlineplus.gov
Clinically, affected patients commonly present with persistent heartburn, acid regurgitation, chest pain, and dysphagia, and prolonged inflammation may progress to complications such as peptic strictures or Barrett's esophagus
Personalize your experience
Follow Reflux esophagitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.